Search

News

You are here: Home / About us / Our Company / News

Media contact

Katie Odgaard, Zyme Communications Ltd.
Tel: +44 (0) 7787 502 947   Email: katie.odgaard@zymecommunications.com

Amber Bielecka, Consilium Strategic Communications.
Tel: +44 (0) 203 709 5700   Email: horizon@consilium-comms.com

Choose Year
2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015


Events

2014

06/12/2014 | Philadelphia, PA
2014 ASCB-IFCB American Society of Cell Biology
The premier meeting for biomedical research worldwide — the 2014 ASCB/IFCB... (more)

02/12/2014 | London
Tumour Models London
Fail Smartly and Learn Fast: Develop and Harness Clinical Relevant Tumour Models This... (more)

25/11/2014 | Liverpool, UK
11th Annual bioprocess UK
Last year nearly 300 delegates from over 120 organisations took part, and this year... (more)

18/11/2014 | Barcelona
26th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics
Hosted by the European Organisation for Research and Treatment of Cancer (EORTC),... (more)

03/11/2014 | Frankfurt, Germany
2014 Bio Europe (Autumn)
The 20th annual BIO-Europe is Europe's largest partnering conference serving the... (more)

21/10/2014 | Boston, USA
Drug Discovery USA Congress
This congress brings together a host of senior level experts to discuss recent developments... (more)

25/09/2014 | Bethesda, Maryland
NIH Research Festival Exhibit
The NIH mission is to expand fundamental knowledge about the nature and behavior... (more)

21/05/2014 | Boston
13th Annual World Pharma Congress
Tackling Translational Challenges After spending 12 years in Philadelphia the World... (more)

05/04/2014 | San Diego
2014 American Association of Cancer Research Annual Meeting
The mission of the AACR is to prevent and cure cancer through research, education,... (more)

10/03/2014 | Turin, Italy
BIO-Europe Spring 2014
BIO-Europe Spring® is the springtime counterpart to EBD Group’s flagship... (more)

18/01/2014 | San Diego
3rd Annual Society for Laboratory Automation and Screening
SLAS is an international community of more than 15,000 individual scientists, engineers,... (more)

News

2014

11/09/2014
Article: A toolkit for the genome
CAMBRIDGE, U.K.—A licensing agreement between Horizon Discovery Group and Stanford... (more)

01/09/2014
Article: Genome Editing Edges to the Clinic
MaryAnn Labant | GEN The programmable, site-specific nuclease systems at the heart... (more)

20/08/2014
Article: What’s next for gene editing? After ‘knock-out’, time for ‘knock-in’
CRISPR gene editing will make cell line development cheaper and faster according... (more)

12/08/2014
Article: Oncology combination drug discovery in the genomics era
Many tumour types find new ways to evade single targeted cancer drugs – hence... (more)

23/06/2014
Article: Removing the hype from IPO
Dr Darrin Disley is President and CEO of Horizon Discovery. A life scientist with... (more)

18/06/2014
Article: As CRISPR-Cas9 Technology Sets to Take Off, Uncertainty Swirls Around IP Landscape
The USPTO recently issued the Broad Institute the first patent for the CRISPR-Cas9... (more)

22/05/2014
Article: Screening Services on the Horizon
Horizon Discovery recently announced that they have agreed to acquire the... (more)

19/05/2014
Award: Horizon named in Santander breakthrough 50 winners 2014
Horizon is the leading life science company supplying research tools to organisations... (more)

19/05/2014
Webinar: Making Ultrasensitive Endogenous NanoLuc® Luciferase Reporter Cell Lines Using CRISPR
Eric Rhodes, Horizon Discovery Group, UKSr. Vice President R&D and Chief Technical... (more)

05/05/2014
Article: CRISPR Gene Editing: It Isn't Quite As Easy As It Looks
In its simplest form, CRISPR gene editing requires only two principal components:... (more)

29/04/2014
Article: Cell-line authentication demystified
Scientists are not easily fooled, but they can unwittingly fool themselves. The identity... (more)

15/04/2014
Article: Understanding the Nuances of Genome Editing
With the emergence of new genome editing technologies such as CRISPR/Cas9, mammalian gene... (more)

27/03/2014
Article: No clouds on this Horizon as company shines in float debut
In its first day of trading on London’s AIM Horizon Discovery, a Cambridge-based... (more)

27/03/2014
Video: Dr. Darrin Disley Interview With CNBC
Horizon Discovery Group plc is a revenue-generating life science company supplying... (more)

24/03/2014
'Test tube patient' maker raises £68.6m in record float
Gene engineering company in biggest ever float for a company from Cambridge's biotech... (more)

24/03/2014
£120.5m valuation will make Horizon Discovery Cambridge's second largest listed biotech
Horizon Discovery will become Cambridge’s second largest publicly listed biotech... (more)

18/03/2014
Announcement: Horizon Discovery is Business Weekly’s BioMedTech Company of the Year
Horizon Discovery is Business Weekly’s BioMedTech Company of the Year. Horizon... (more)

27/02/2014
Horizon Discovery’s planned Aim float points to UK biotech pick-up
A company that helps drugmakers research the genetic mutations that cause disease... (more)

27/02/2014
Horizon floats to boost ‘gene editing’
A Cambridge-based genetic analysis company is to join the recent rush for stockmarket... (more)

27/02/2014
'Test tube patient' maker to float on Aim
Gene engineering company Horizon Discovery hopes to raise £25m on London's... (more)

19/02/2014
Article: Collaborations on the Horizon
Horizon Discovery have announced distribution agreements with Haplogen and Sirion... (more)

18/02/2014
Article: A CRISPR collaboration
CAMBRIDGE, UK: Horizon Discovery and biotechnology company Desktop Genetics... (more)

03/02/2014
LabTube Meets Chris Torrance, Horizon Discovery at SLAS2014
Society for Laboratory Automation and Screening Annual Meeting   Click... (more)

03/02/2014
LabTube Meets Paul Morrill, Horizon Discovery at SLAS2014
Society for Laboratory Automation and Screening Annual Meeting Click Here to view... (more)

13/01/2014
Article: Horizon Discovery bags second AstraZeneca contract
All the obvious cancer targets have been found according to Horizon Discovery, which... (more)

Press releases

2014

05/08/2014
Horizon Discovery Adds Three Eminent CRISPR Experts to its Scientific Advisory Board
Dr. Emmanuelle Charpentier, Dr. J. Keith Joung, and Dr. Feng Zhang join Horizon’s... (more)

25/07/2014
Horizon Discovery and Otsuka Pharmaceutical Development and Commercialization Sign Collaboration Agreement
Horizon CombinatoRx to perform in-vitro cell line screening of OPDC clinical... (more)

03/07/2014
Horizon Discovery Licenses AAV Gene Delivery Technology from Stanford University
Supplements existing exclusive rAAV gene targeting license from University of Washington Cambridge,... (more)

20/06/2014
Horizon Discovery Wins European Mediscience’s Emerging Star Award 2014
Cambridge, UK, 20th June 2014: Horizon Discovery Group plc (LSE: HZD) (Horizon),... (more)

16/06/2014
Horizon Discovery and LGC Awarded Technology Strategy Board Grant to Develop Standardization for Next Generation Cancer Diagnostics
Improving minimally invasive circulating DNA diagnostic assays supports implementation... (more)

12/06/2014
Horizon Discovery Licenses CRISPR Gene Editing Technology from the Broad Institute
Cambridge, UK, 12 June 2014: Horizon Discovery™ Group plc (LSE:HZD) (Horizon),... (more)

09/06/2014
Horizon Discovery Strengthens Board with Appointment of Dr Susan Galbraith and Susan Searle as Non-Executive Directors
Cambridge, UK, 9 June 2014: Horizon Discovery™ Group plc (LSE: HZD) (“Horizon”... (more)

02/06/2014
Horizon Discovery Group plc Completes Acquisition of CombinatoRx Service Business and Assets from Zalicus Inc.
Acquisition of revenue generating and complementary business establishes Horizon’s... (more)

15/05/2014
Horizon Discovery Group plc to Acquire CombinatoRx Service Business and Assets from Zalicus Inc.
Adds high-throughput screening, drug combination sciences and scalable bioinformatics... (more)

08/05/2014
Horizon Discovery Licenses CRISPR Cas9 Gene Editing Technology from ERS Genomics
Cambridge, UK, 8 May 2014: Horizon Discovery™ Group plc (LSE: HZD) (“Horizon”... (more)

16/04/2014
Re. Share Price Movement
Re. Share Price Movement Horizon Discovery Group plc (“Horizon” or “the... (more)

11/04/2014
Employee SAYE Share Plan
Employee SAYE Share Plan The Company has established a H.M. Revenue and Customs... (more)

07/04/2014
Horizon Discovery Launches New GENASSIST CRISPR and rAAV Gene Editing Tools and Services
Comprehensive product and service solution enables easier, robust implementation... (more)

27/03/2014
Horizon Discovery Group plc
THIS ANNOUNCEMENT IS FOR INFORMATION PURPOSES ONLY AND DOES NOT CONSTITUTE OR FORM... (more)

24/03/2014
Horizon Discovery Group plc Raises £68.6 million
THIS ANNOUNCEMENT IS FOR INFORMATION PURPOSES ONLY AND DOES NOT CONSTITUTE OR FORM... (more)

27/02/2014
Horizon Discovery Group plc Announces Intention to Float
THIS ANNOUNCEMENT IS FOR INFORMATION PURPOSES ONLY AND DOES NOT CONSTITUTE OR FORM... (more)

17/02/2014
Horizon Discovery Signs Supply and Distribution Agreement with Sirion Biotech GmbH
Agreement adds custom and off-the-shelf shRNA and cDNA expression capabilities to... (more)

12/02/2014
Horizon Discovery Signs Distribution Agreement with Haplogen
Horizon will market and distribute haploid gene trap mutant collection to its global... (more)

10/02/2014
Horizon Discovery Launches GENASSIST Line of Kits and Reagents for Gene-Editing, utilizing CRISPR Technology
New CRISPR-ready cell line kit and validated RNA guide service to enable easier,... (more)

30/01/2014
Horizon Discovery Signs Large-Scale License Agreement for its X-MAN Cell Lines in Japan
Agreement covers use of 250 of Horizon’s X-MAN genetically defined isogenic... (more)

16/01/2014
Horizon Discovery and Transgenomic Announce Collaboration for Validation Control and Development of Genetic Diagnostic Tests
Transgenomic will use Horizon’s genetically defined reference standards in... (more)

14/01/2014
Dr. Ian Gilham Appointed Chairman of the Board for Horizon Discovery
Cambridge, UK, 14 January 2014: Horizon Discovery (Horizon), a leading provider of... (more)

07/01/2014
Horizon Discovery Announces Oncology Research, Collaboration and License Agreement with AstraZeneca
Cambridge, UK, 07 January 2014: Horizon Discovery (Horizon) and AstraZeneca have... (more)

Paragraph explaining benefits of Biocair

×

Login Error


There was an error with your login - please try again.

Forgotten your password? Click here

OK ×

Recover your password

Please enter your email address and we'll send you a reset link

×

Thank you.


We've sent you an email to reset your password.

OK ×

Add Voucher


Sorry, Unable to add voucher

OK ×

Account Error


There was an error updating your details.

OK ×

Thank you.


Your changes have been saved.

OK ×

Thank you


Thank you for registering to the Horizon Discovery website. We hope you enjoy and benefit from our online resources, and please feel free to contact us if you have any queries or feedback through the website itself or at info@horizondiscovery.com.


Got a few seconds to tell us what you're interested in?



Tick all that apply:

Horizon’s Offerings

Application Area

Disease Area

 

Other Disease Area (Please specify)


OK
×

Thank you.


Items have been saved to your basket.

OK ×